MORGAN STANLEY - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 51 filers reported holding REGULUS THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$0
-100.0%
1,834
+0.5%
0.00%
Q2 2018$1,0000.0%1,825
-1.6%
0.00%
Q1 2018$1,000
-66.7%
1,854
-35.4%
0.00%
Q4 2017$3,000
-57.1%
2,872
-49.6%
0.00%
Q3 2017$7,000
-89.9%
5,699
-91.8%
0.00%
Q2 2017$69,000
-66.2%
69,916
-43.6%
0.00%
Q1 2017$204,000
-64.3%
124,030
-51.2%
0.00%
Q4 2016$572,000
+450.0%
254,016
+701.1%
0.00%
Q3 2016$104,000
+28.4%
31,708
+13.2%
0.00%
Q2 2016$81,000
-61.8%
28,009
-8.7%
0.00%
Q1 2016$212,000
-35.8%
30,663
-18.9%
0.00%
Q4 2015$330,000
+46.0%
37,820
+9.3%
0.00%
Q3 2015$226,000
-29.6%
34,606
+18.5%
0.00%
Q2 2015$321,000
-29.6%
29,194
+8.5%
0.00%
Q1 2015$456,000
+338.5%
26,906
+313.5%
0.00%
Q4 2014$104,000
+44.4%
6,507
-37.7%
0.00%
Q3 2014$72,000
-20.9%
10,441
-7.7%
0.00%
Q2 2014$91,000
+810.0%
11,309
+943.3%
0.00%
Q1 2014$10,000
-84.1%
1,084
-87.3%
0.00%
Q4 2013$63,000
-84.0%
8,507
-78.8%
0.00%
Q2 2013$393,00040,0750.00%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
RA Capital Management 4,039,823$26,420,0003.79%
Foresite Capital Management II, LLC 1,750,269$11,447,0003.48%
ARGONAUT CAPITAL MANAGEMENT CORP 75,000$491,0001.65%
Abingworth LLP 327,350$2,138,0001.25%
Trellus Management Company, LLC 100,000$654,0000.96%
Cormorant Asset Management, LP 896,522$5,863,0000.94%
DAFNA Capital Management LLC 90,000$589,0000.58%
ORACLE INVESTMENT MANAGEMENT INC 749,064$4,898,0000.50%
Foresite Capital Management II, LLC 250,000$1,635,0000.50%
Foresite Capital Management II, LLC 250,000$1,635,0000.50%
View complete list of REGULUS THERAPEUTICS INC shareholders